Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Olympus Biotech
Olympus Biotech
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Opgenra
Eptotermin alfa
2009-02-19
Spondylolisthesis
,
Tibial fractures
Osigraft
Eptotermin alfa
2001-05-17
Spondylolisthesis
,
Tibial fractures
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Eptotermin alfa
healthy volunteers/patients
,
knee osteoarthritis
,
osteoarthritis
,
malocclusion
,
cataract
,
carcinoma
,
oropharyngeal neoplasms
,
alzheimer disease
,
tibial fractures
,
spondylolisthesis
,
osteonecrosis
,
femur head necrosis
,
necrosis
,
intervertebral disc degeneration
,
joint diseases
,
sleep wake disorders
,
dyssomnias
,
parasomnias
Trafermin
periodontitis
,
diabetic foot
,
ulcer
,
foot ulcer
,
tympanic membrane perforation
,
alveolar bone loss
,
periodontal attachment loss
Aspartame
pancytopenia
,
hemoglobinopathies
,
bone marrow failure disorders
,
inborn errors metabolism
,
primary immunodeficiency diseases
Bevifimod
neoplasms
,
pancreatic neoplasms
,
recurrence
,
sarcoma
,
brain neoplasms
,
glioblastoma
,
gliosarcoma
,
herpes simplex
,
herpes genitalis
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
follicular lymphoma
,
renal cell carcinoma
,
carcinoma
,
uterine cervical neoplasms
,
central nervous system neoplasms
,
nervous system neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use